IOPs Health Impact Monitoring:

We estimate the public health impact of IOP sales.

Adverse drug reactions represent a significant healthcare cost. Medicines sold through IOPs provoke significantly more adverse reactions than those subject to proper regulatory and medical oversight. Our method estimates the extra adverse drug reactions generated by medicines sold through IOPs and the healthcare costs associated with these additional adverse reactions. These estimates are very helpful to regulators, policy-makers, and researchers who need to assess the health impact of such drugs and expose the risks posed by their illicit sellers.

Health Impact

We provide monthly estimates of the extra adverse drug reactions due to sales of medicines from IOPs—reactions that would have been avoided if these medicines had been sold through legal pharmacies. These estimates are provided at different levels of granularity (active ingredient, therapeutic category, drug manufacturer, or the whole industry).

Healthcare Costs

Our service estimates the monthly healthcare costs of the adverse drug reactions that would have been avoided had IOPs sales taken place through legal pharmacies instead. These estimates are provided at different levels of granularity (active ingredient, therapeutic category, drug manufacturer, or the whole industry).

Other services

IOPs Network Monitoring

IOPs form a network composed by thousands of densely interconnected nodes. This network is highly dynamic, with nodes dying out and new nodes arising, continuously modifying the network’s topology. Our IOPs Network Monitoring service maps this network and follows its temporal evolution, identifying the most active and central nodes at any given time.

IOP Sales Monitoring

IOPs sell thousands of distinct medicines in varying amounts. Our IOPs Sales Monitoring service estimates the volume traded for each medicine and the economic loss this represents for the legitimate pharmaceutical industry.